Jo Cato, Ph.D.

Analyst

Dr. Cato is an Analyst of Cato BioVentures. He also serves as the Managing Director of the San Diego and South San Francisco offices of Cato Research. Dr. Cato has 12 years’ experience in drug development with expertise in drug metabolism and mathematical modeling, clinical pharmacokinetic study design, data analysis and reporting, preclinical pharmacokinetics and toxicokinetics.  He served as a pharmacokineticist for both Abbott Laboratories (NYSE: ABT) and Ligand Pharmaceuticals (NASDAQ: LGNDE).